Turning great ideas into healthier communities

Rosemary Cress, DrPH

Dr. Rosemary Cress is a Research Program Director with the Public Health Institute’s Cancer Registry of Greater California (CRGC), the largest of three population based cancer registries that make up the California Cancer Registry. The CRGC collects information on all cancers diagnosed among residents of a broad geographic area with a diverse population of nearly 20 million people residing in 48 of the 58 counties of California (all of California except for Los Angeles County and the San Francisco Bay Area). Her research activities are focused primarily on use of cancer registry data to identify disparities in treatment and survival for California cancer patients by race, ethnicity, socioeconomic status, health system factors, and age. She also works with academic researchers, clinical faculty and graduate students at UC Davis and other academic institutions to identify areas where California Cancer Registry and SEER data can be used to answer questions about cancer diagnosis, treatment and survival. Dr. Cress is an associate professor of epidemiology at the UC Davis School of Medicine where she teaches cancer epidemiology. Dr. Cress received her doctorate in epidemiology from the Tulane University School of Public Health and Tropical Medicine, and has been with the Public Health Institute’s registry program since 1995.

SEER Linked Virtual Tissue Repository

The Cancer Registry of Greater California (CRGC) will 1) assess the ability of SEER Contractor Registries to serve as a resource for biospecimen research, 2) locate patients with biospecimens in pathology laboratories and determine the requirements to retrieve those biospecimens, 3) provide custom annotation of specified data items, 4) capture costs for identifying each available biospecimen and performing custom annotation of each biospecimen.

Adjuvant Chemotherapy for Patients with Stage III Colon Cancer: Results from a CDC-NPCR Patterns of Care Study (2009)

This study evaluates adjuvant chemotherapy use for Stage III colon cancer, reviewing the treatment of patients with surgically treated stage III co...

View Details »

Cancer

According to the WHO, cancer is among the leading causes of morbidity and mortality worldwide, with approximately 14 million new cases and 8.2 mill...

View Details »

Research - Surveillance

Understanding emerging and existing health threats begins with good data. Public health surveillance ensures that researchers, programs, and policy...

View Details »